• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.

作者信息

van Ingen Jakko, Wagner Dirk, Gallagher Jack, Morimoto Kozo, Lange Christoph, Haworth Charles S, Floto R Andres, Adjemian Jennifer, Prevots D Rebecca, Griffith David E

机构信息

Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands

Both authors contributed equally.

出版信息

Eur Respir J. 2017 Feb 15;49(2). doi: 10.1183/13993003.01855-2016. Print 2017 Feb.

DOI:10.1183/13993003.01855-2016
PMID:28182571
Abstract
摘要

相似文献

1
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.非结核分枝杆菌肺病患者对管理指南的依从性较差。
Eur Respir J. 2017 Feb 15;49(2). doi: 10.1183/13993003.01855-2016. Print 2017 Feb.
2
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.非结核分枝杆菌肺病的治疗结局定义：一份非结核分枝杆菌网络共识声明
Eur Respir J. 2018 Mar 22;51(3). doi: 10.1183/13993003.00170-2018. Print 2018 Mar.
3
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).英国胸科学会非结核分枝杆菌肺病（NTM-PD）管理指南。
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64. doi: 10.1136/thoraxjnl-2017-210927.
4
Adjuvant surgical treatment of nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病的辅助外科治疗。
Ann Thorac Surg. 2013 Jul;96(1):287-91. doi: 10.1016/j.athoracsur.2013.03.008. Epub 2013 Apr 22.
5
Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病缺乏对循证治疗指南的依从性。
Ann Am Thorac Soc. 2014 Jan;11(1):9-16. doi: 10.1513/AnnalsATS.201304-085OC.
6
Antibiotic treatment for nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病的抗生素治疗
Expert Rev Respir Med. 2016;10(5):557-68. doi: 10.1586/17476348.2016.1165611. Epub 2016 Mar 30.
7
Non-tuberculous mycobacterial pulmonary disease: a clinical update.非结核分枝杆菌肺病：临床进展
Br J Hosp Med (Lond). 2018 Aug 2;79(8):C118-C122. doi: 10.12968/hmed.2018.79.8.C118.
8
Invited commentary.特邀评论。
Ann Thorac Surg. 2013 Jul;96(1):292. doi: 10.1016/j.athoracsur.2013.04.037.
9
Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species.儿童肺移植的结果因脓肿分枝杆菌复合群菌种而异。
Eur Respir J. 2013 May;41(5):1230-2. doi: 10.1183/09031936.00143512.
10
[Recommendations for diagnosis and treatment of nontuberculous mycobacterioses of the German Central Committee against tuberculosis and the German Respiratory Society].[德国抗结核中央委员会和德国呼吸学会关于非结核分枝杆菌病的诊断和治疗建议]
Pneumologie. 2013 Nov;67(11):605-33. doi: 10.1055/s-0033-1344790. Epub 2013 Nov 6.

引用本文的文献

1
Multicentre retrospective observational study for development and validation of MAC prognostic score model.多中心回顾性观察研究以建立和验证MAC预后评分模型。
Sci Rep. 2025 Aug 5;15(1):28539. doi: 10.1038/s41598-025-14348-7.
2
Investigation of WQ-3810, a Fluoroquinolone with a High Potential Against Fluoroquinolone-Resistant .对WQ-3810的研究，一种对耐氟喹诺酮类药物具有高潜力的氟喹诺酮类药物
Antibiotics (Basel). 2025 Jul 14;14(7):704. doi: 10.3390/antibiotics14070704.
3
Insights from the European Nontuberculous mycobacterial pulmonary disease PAtient Disease Experience (ENPADE) survey- exploring disease burden and impact.
欧洲非结核分枝杆菌肺病患者疾病体验（ENPADE）调查的见解——探索疾病负担和影响
BMC Pulm Med. 2025 Feb 21;25(1):85. doi: 10.1186/s12890-025-03553-9.
4
Comprehensive Management Algorithm for Complex Pulmonary Disease in the Real-World Setting.真实世界中复杂肺部疾病的综合管理算法
Ann Am Thorac Soc. 2025 May;22(5):651-659. doi: 10.1513/AnnalsATS.202408-904FR.
5
Drug-drug interactions in the management of non-tuberculous mycobacterial infections.非结核分枝杆菌感染管理中的药物相互作用。
Front Microbiol. 2024 Sep 5;15:1468383. doi: 10.3389/fmicb.2024.1468383. eCollection 2024.
6
Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者纵向随访期间新发慢性阻塞性肺疾病的风险。
Respir Res. 2024 Sep 9;25(1):333. doi: 10.1186/s12931-024-02963-3.
7
Supporting Patients with Nontuberculous Mycobacterial Pulmonary Disease: Ensuring Best Practice in UK Healthcare Settings.支持非结核分枝杆菌肺病患者：确保英国医疗环境中的最佳实践。
Pharmacy (Basel). 2024 Aug 21;12(4):126. doi: 10.3390/pharmacy12040126.
8
Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的管理挑战与结局
IJTLD Open. 2024 Jul 1;1(7):332-334. doi: 10.5588/ijtldopen.24.0140. eCollection 2024 Jul.
9
Evaluation of a national multidisciplinary meeting for non-tuberculous mycobacterial disease.非结核分枝杆菌病全国多学科会议评估
IJTLD Open. 2024 Jun 1;1(6):279-281. doi: 10.5588/ijtldopen.24.0044. eCollection 2024 Jun.
10
Real-World Patients' Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey.非结核分枝杆菌肺病患者从诊断到治疗的真实世界历程：一项横断面调查
Infect Dis Ther. 2024 Aug;13(8):1907-1920. doi: 10.1007/s40121-024-01015-z. Epub 2024 Jul 10.